Dr. Ahmad Ramahi, MD

Dr. Ramahi practices at Kymera Independent Physicians in Roswell, New Mexico.

Dr. Ramahi's NPI, 1457872350, was assigned on June 29, 2017. Dr. Ramahi holds New Mexico license MD2022-0183.

Dr. Ramahi's primary practice is Kymera Independent Physicians, at 400 Military Heights Pl, Roswell, NM 88201-6407. The practice phone is (575) 627-9500.

Dr. Ramahi's primary practice is Kymera Independent Physicians in Roswell, New Mexico. Dr. Ramahi is also affiliated with CHRISTUS Health. The medical group on file is Kymera Independent Physicians. Dmand AI also links Dr. Ramahi to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ramahi practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Ramahi's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Dr. Ramahi's licenses on file in 2 states: New Mexico and Michigan.

CMS data shows 58,194 Medicare services from Dr. Ramahi across 40 procedure codes in 2024, for 326 Medicare patients. Medicare paid $593,377 for them. Every service was in an office.

CMS counts 326 Medicare patients who saw Dr. Ramahi in 2024. The largest group is 65 to 74, with 145 patients. 75% of them have arthritis, and 75% have high blood pressure. 29% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ramahi's median patient age at 61, with 77% women.

In 2024, Dr. Ramahi wrote 1,802 Medicare Part D claims for 289 patients. 67% of them were for generic drugs. CMS names the drug for 1,703 of them, across 26 drugs with 11 or more claims each, at $3,262,146 in total drug cost. In 2023, CMS named 2,041 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ramahi for performance year 2024, reported as part of a group. Dr. Ramahi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ramahi as offering telehealth.

Dmand AI links 10 papers to Dr. Ramahi, published from 2012 to 2022. 2019 was the busiest year, with 3. The most frequent topics are Scleroderma, Systemic. Dr. Ramahi has published most often in Cureus. Dr. Ramahi's most frequent co-authors are Kanana Mohammad Aburayyan, Nezam Ibrahim Altorok and Dinesh Khanna, MD.

CMS Open Payments shows 32 general payments to Dr. Ramahi from 20 drug and device companies from 2020 to 2025. Grants make up the largest share, 98% of the total. Pfizer Inc. paid the most, $34,583.